Iqvia Holdings IQV
NYSE IQV
$262.13 +0.62 (+0.24%)
As of: Aug 27, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011)

Iqvia Holdings (IQV) posted Asset Writedowns and Impairment of $12.2 million for Q4 2011.

Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011) Analysis & Trends

Iqvia Holdings has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $12.2 million in Q4 2011.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $12.2 million in Q4 2011, while the trailing twelve-month figure through Dec 2017 was $12.2 million (changed N/A YoY) and the FY2017 annual result came in at $40.0 million, up 42.86% from the prior year.
  • Asset Writedowns and Impairment was little changed at $12.2 million in Q4 2011 per IQV's latest filing.
  • Over five years, Asset Writedowns and Impairment peaked at $12.2 million in Q4 2011 and troughed at $12.2 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Dec 31, 2011 12.20 Mn
Dec 31, 2011 12.20 Mn